Postnatal adaptations of phosphatidylcholine metabolism in extremely preterm infants: implications for choline and

Kevin C W Goss1,2, Victoria M Goss2, J Paul Townsend2

  • 1Child Health, Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Insights

Extremely preterm infants have immature livers that actively synthesize phosphatidylcholine (PC) via the CDP-choline pathway. Low PEMT activity suggests a need for increased choline and PUFA supplementation in parenteral nutrition.

Area of Science:

  • Neonatal physiology and metabolism
  • Lipidomics and molecular pathways
  • Nutritional biochemistry

Background:

  • Pregnancy involves maternal liver delivery of polyunsaturated fatty acids (PUFAs) to the fetus.
  • Extremely preterm infants face challenges transitioning to PUFA-poor diets post-birth, often relying on total parenteral nutrition.
  • Immature liver function in preterm neonates impacts essential nutrient metabolism.

Purpose of the Study:

  • To characterize phosphatidylcholine (PC) and choline metabolism in preterm infants.
  • To demonstrate the molecular specificity of PC synthesis by the immature preterm liver in vivo.
  • To assess postnatal adaptations in plasma PC composition.

Main Methods:

  • Lipidomic analysis using mass spectrometry (MS) in 31 preterm infants (<28 weeks' gestational age).
  • Quantification of postnatal adaptations in plasma PC molecular composition.
  • Assessment of cytidine diphosphocholine (CDP-choline) and phosphatidylethanolamine-N-methyltransferase (PEMT) pathway activities using deuterated methyl-D9-choline chloride incorporation.

Main Results:

  • Plasma PC concentrations significantly increased postnatally (481 µM to 1046 µM within 5 days).
  • The CDP-choline pathway actively synthesized PC, enriched in oleic and linoleic acids.
  • Liver PEMT activity was found to be very low, indicating minimal endogenous choline synthesis.

Conclusions:

  • The preterm infant liver is metabolically active in lipoprotein metabolism shortly after birth.
  • Low PEMT activity highlights the critical need for increased choline and PUFA supplementation in preterm parenteral nutrition.
  • Findings support enhanced nutritional support for extremely preterm infants to optimize lipid metabolism.
Abstract

Related Concept Videos

Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
3.8K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
35.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
614